BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mu X, Wang C. Artemisinins—a Promising New Treatment for Systemic Lupus Erythematosus: a Descriptive Review. Curr Rheumatol Rep 2018;20. [DOI: 10.1007/s11926-018-0764-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Feng X, Cao S, Qiu F, Zhang B. Traditional application and modern pharmacological research of Artemisia annua L. Pharmacology & Therapeutics 2020;216:107650. [DOI: 10.1016/j.pharmthera.2020.107650] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
2 Alagbonsi AI, Salman TM, Sulaiman SO, Adedini KA, Kebu S. Possible mechanisms of the hypoglycaemic effect of artesunate: Gender implication. Metabol Open 2021;10:100087. [PMID: 33778463 DOI: 10.1016/j.metop.2021.100087] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Chen Q, Wang Z, Lv J, Liu L, Li H, Sun W, Huo Y, Guo Y, Shen C, Li S, Chen Z, Zhou J. Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial. Trials 2022;23:444. [PMID: 35614482 DOI: 10.1186/s13063-022-06336-3] [Reference Citation Analysis]
4 Meng Y, Ma N, Lyu H, Wong YK, Zhang X, Zhu Y, Gao P, Sun P, Song Y, Lin L, Wang J. Recent pharmacological advances in the repurposing of artemisinin drugs. Med Res Rev 2021. [PMID: 34148245 DOI: 10.1002/med.21837] [Reference Citation Analysis]
5 Protti M, Mandrioli R, Mandrone M, Cappadone C, Farruggia G, Chiocchio I, Malucelli E, Isani G, Poli F, Mercolini L. Analysis of Artemisia annua extracts and related products by high performance liquid chromatography-tandem mass spectrometry coupled to sample treatment miniaturisation. J Pharm Biomed Anal 2019;174:81-8. [PMID: 31158609 DOI: 10.1016/j.jpba.2019.05.044] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kadioglu O, Klauck SM, Fleischer E, Shan L, Efferth T. Selection of safe artemisinin derivatives using a machine learning-based cardiotoxicity platform and in vitro and in vivo validation. Arch Toxicol 2021;95:2485-95. [PMID: 34021777 DOI: 10.1007/s00204-021-03058-4] [Reference Citation Analysis]
7 Yu C, Li Y, Chen G, Wu C, Wang X, Zhang Y. Bioactive constituents of animal-derived traditional Chinese medicinal materials for breast cancer: opportunities and challenges. J Zhejiang Univ Sci B 2022;23:547-63. [PMID: 35794685 DOI: 10.1631/jzus.B2101019] [Reference Citation Analysis]
8 Lu BW, Xie LK. Potential applications of artemisinins in ocular diseases. Int J Ophthalmol 2019;12:1793-800. [PMID: 31741871 DOI: 10.18240/ijo.2019.11.20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zhang H, Li G, Yang J, Chen A, Xie M. Supercritical-derived artemisinin microfibers and microparticles for improving anticancer effects. The Journal of Supercritical Fluids 2021;175:105276. [DOI: 10.1016/j.supflu.2021.105276] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Augustin Y, Staines HM, Krishna S. Artemisinins as a novel anti-cancer therapy: Targeting a global cancer pandemic through drug repurposing. Pharmacol Ther 2020;216:107706. [PMID: 33075360 DOI: 10.1016/j.pharmthera.2020.107706] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
11 Xia M, Liu D, Tang X, Liu Y, Liu H, Liu Y, Chen G, Liu H. Dihydroartemisinin inhibits the proliferation of IgAN mesangial cells through the mTOR signaling pathway. Int Immunopharmacol 2020;80:106125. [PMID: 31931362 DOI: 10.1016/j.intimp.2019.106125] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
12 Wang X, Du H, Li X. Artesunate attenuates atherosclerosis by inhibiting macrophage M1-like polarization and improving metabolism. Int Immunopharmacol 2022;102:108413. [PMID: 34891003 DOI: 10.1016/j.intimp.2021.108413] [Reference Citation Analysis]
13 Lei XY, Tan RZ, Jia J, Wu SL, Wen CL, Lin X, Wang H, Shi ZJ, Li B, Kang Y, Wang L. Artesunate relieves acute kidney injury through inhibiting macrophagic Mincle-mediated necroptosis and inflammation to tubular epithelial cell. J Cell Mol Med 2021. [PMID: 34337860 DOI: 10.1111/jcmm.16833] [Reference Citation Analysis]
14 Li X, He Z, Ru L, Yuan Y, Yuan Z, Chen P, Xu Z, Wang Q, Song J, Xu Q. Efficacy and Safety of Qinghao Biejia Decoction in the Treatment of Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis. Front Pharmacol 2021;12:669269. [PMID: 34421590 DOI: 10.3389/fphar.2021.669269] [Reference Citation Analysis]
15 Xia M, Liu D, Liu Y, Liu H. The Therapeutic Effect of Artemisinin and Its Derivatives in Kidney Disease. Front Pharmacol 2020;11:380. [PMID: 32296335 DOI: 10.3389/fphar.2020.00380] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Cheng X, Yan H, Pang S, Ya M, Qiu F, Qin P, Zeng C, Lu Y. Liposomes as Multifunctional Nano-Carriers for Medicinal Natural Products. Front Chem 2022;10:963004. [DOI: 10.3389/fchem.2022.963004] [Reference Citation Analysis]
17 Elfahmi E, Cahyani FM, Kristianti T, Suhandono S. Transformation of Amorphadiene Synthase and Antisilencing P19 Genes into Artemisia annua L. and its Effect on Antimalarial Artemisinin Production. Adv Pharm Bull 2020;10:464-71. [PMID: 32665907 DOI: 10.34172/apb.2020.057] [Reference Citation Analysis]